Sequoia Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$636K Sell
2,805
-688
-20% -$123K ﹤0.01% 1183
2026
Q1
$603K Buy
3,493
+285
+9% +$52.8K ﹤0.01% 1169
2025
Q4
$640K Sell
3,208
-1
-0% -$181 ﹤0.01% 1134
2025
Q3
$502K Sell
3,209
-223
-6% -$35.4K ﹤0.01% 1136
2025
Q2
$521K Buy
3,432
+1,677
+96% +$224K ﹤0.01% 977
2025
Q1
$264K Sell
1,755
-207
-11% -$34.7K ﹤0.01% 1117
2024
Q4
$362K Sell
1,962
-7,569
-79% -$1.46M ﹤0.01% 937
2024
Q3
$1.88M Sell
9,531
-4,685
-33% -$974K 0.02% 390
2024
Q2
$2.94M Buy
14,216
+665
+5% +$151K 0.04% 259
2024
Q1
$3.67M Sell
13,551
-557
-4% -$133K 0.05% 232
2023
Q4
$3.34M Buy
14,108
+13,068
+1,257% +$2.57M 0.04% 259
2023
Q3
$204K Buy
1,040
+5
+0.5% +$1.03K ﹤0.01% 861
2023
Q2
$218K Sell
1,035
-37
-3% -$7.36K ﹤0.01% 835
2023
Q1
$216K Buy
1,072
+26
+2% +$5.89K ﹤0.01% 739
2022
Q4
$228K Buy
+1,046
New +$228K 0.01% 686

Other funds holding CRL

Sequoia Financial Advisors's CRL Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Charles River Laboratories (CRL) stake by 20% in Q2 2026, selling an estimated $123K and leaving 2,805 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Sequoia Financial Advisors first reported a position in CRL in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.67M in Q1 2024. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Sequoia Financial Advisors held 2,805 shares of Charles River Laboratories worth $636K as of Q2 2026.
  • Sequoia Financial Advisors sold 688 Charles River Laboratories shares in Q2 2026, an estimated $123K.
  • Charles River Laboratories made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1183 holding.
  • Sequoia Financial Advisors first reported a position in Charles River Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Sequoia Financial Advisors's Charles River Laboratories position peaked at $3.67M in Q1 2024.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.